SCHEMBL25945837

SCHEMBL25945837

CN(C)C(=O)/C=C/CCCC(=O)Nc1cccn(Cc2cc3cc(F)cc(C(F)(F)F)c3[nH]2)c1=O

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25945992 0.88 MAP4K1 (0.53) MAP4K1
SCHEMBL25944432 0.87 MAP4K1 (0.70) MAP4K1
SCHEMBL25945536 0.87 MAP4K1 (0.62) MAP4K1
SCHEMBL25945474 0.85 MAP4K1 (0.64) MAP4K1
SCHEMBL21683637 0.84 MAP4K1 (0.80) MAP4K1
SCHEMBL21683639 0.84 MAP4K1 (0.80) MAP4K1
SCHEMBL21683634 0.84 MAP4K1 (0.80) MAP4K1
SCHEMBL31450695 0.83 MAP4K1 (0.60) MAP4K1
SCHEMBL25945558 0.82 MAP4K1 (0.75) MAP4K1
SCHEMBL25944753 0.81 MAP4K1 (0.73) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed